[Danazol in congenital hypofibrinogenemia: 2 paradoxical effects].
D000328:Adult; D000347:Afibrinogenemia / Q000151:congenital* / Q000188:drug therapy; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008297:Male; D008595:Menorrhagia / Q000139:chemically induced*; D011245:Pregnadienes / Q000009:adverse effects / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000139:chemically induced*
D011245:Pregnadienes; D005340:Fibrinogen; D003613:Danazol
Danazol en hipofibrinogenemia congénita: dos efectos paradójicos.